A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replace
The Texas AG has filed a lawsuit accusing Sanofi of providing kickbacks to doctors, in the form of a free network of nurses and insurance support services.
Breathing polluted air may do more than harm your lungs — it could also increase your risk of Alzheimer’s disease. In a sweeping study of nearly 28 million older Americans, researchers found that long term exposure to fine particle air pollution was linked to a higher likelihood of developing Alzheimer’s. The connection appeared to stem largely from pollution’s direct effects on the brain, rather
A sweeping new study has uncovered a troubling mix of hazardous chemicals in popular hair extensions, including products made from human hair. Researchers detected dozens of substances linked to cancer, hormone disruption, reproductive harm, and immune system effects in nearly every sample tested. Some products contained flame retardants, organotins, and chemicals associated with increased breast
A blood test for detecting cancer early being developed by the diagnostics firm Grail failed to meet its main goal in a giant study being conducted with England’s National Health…
The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots given to infants.
Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening with Moderna and FDA? Find out on "The Readout…
FDA has tapped a former executive from a health AI company to lead its digital health center.
Patients have long had to navigate error-prone lists of doctors and hospitals.
Find out who's on the rise inside RFK Jr.'s federal health department.
As recent changes to U.S. vaccine policy face pushback on several fronts, one of the key bodies driving the nation's immunization recommendations is postponing its meeting previously planned for next week.
The combination of Padcev and Keytruda has once again delivered strong results, this time significantly improving overall survival for patients with cisplatin-eligible muscle-invasive bladder cancer. Yet questions remain about its impact on practice due to a changing treatment landscape.
In this edition of STAT Health Tech: A new wave of AI-guided cancer treatments, a Hims acquisition, and other health tech news.
FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring
In this episode of "The Top Line," Fierce Pharma's Fraiser Kansteiner speaks with Atradius' Brady McKinney about how tariff pressures drove a 2025 manufacturing surge in pharma and why production is expected to stabilize in the years ahead.
Throughout 2025, the world's first metabolic dysfunction-associated steatohepatitis (MASH) drug generated just shy of a billion dollars. But Madrigal has much more growth in mind for the years to come.
Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.
In a fourth-quarter conference call, Insmed CEO Will Lewis admitted that it was “audacious” that his company would project sales of newly approved respiratory drug Brinsupri to reach $1 billion in 2026. Then he laid out the case why the projection isn't so cheeky.
An untitled letter shared to the agency’s public database this month homes in on certain details of a commercial touting Tremfya’s use in ulcerative colitis.
A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic disease. Using a drug to boost these molecules reduced pain faster and lowered harmful inflammatory cells. The discovery could pave the way for safer treatments for arthritis, heart disease, and othe